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j  chain was originally described as a  highly acidic component of the polymeric 
secretory immunoglobulins IgM and IgA. Structural work has demonstrated a disul- 
fide bridge between it and a  cysteine present on the C  terminus of both secretory # 
and a  heavy chains, and studies on the biosynthesis of these proteins have led to the 
view that J  chain is, via this linkage, involved in the polymerization of multimerie 
immunoglobulins (1, 2). 
A  number of observations, however, would require certain  modifications of this 
hypothesis. Some secretory IgM and IgA have been found to exist in a polymeric state 
in  the  absence  of J  chain  (3,  4),  and  polymerization  of  monomers  can  occur 
independently both in vivo (5) and in vitro (6, 7). J  chain synthesis has been detected 
in plasma cells producing IgG or light (L) x chains only, as well as in variants selected 
to be defective in heavy (H)  and/or L  chain synthesis (8-12).  Immunofluoreseence 
studies  have  shown  that  J  chain  synthesis  increases  parallel  to  Ig  synthesis  as 
lymphoeytes are  stimulated  by  mitogens  (13).  Although  some  investigators  have 
reported that resting, surface Ig  + B lymphocytes are negative, recent evidence with 
more sensitive immunocytochemical techniques indicates that  they, too, contain J 
chain (14). These observations suggest that J  chain biosynthesis is not solely linked to 
the secretion of polymeric immunoglobulins by plasma cells. 
Recently, a number of unusual human cell lines have been derived in this laboratory 
from patients with various disorders (15,  16). These cell lines, which phenotypically 
resemble precursors in the B cell lineage, are readily amenable to the analysis of events 
surrounding immunoglobulin synthesis and the ontogeny thereof. To identify more 
precisely  the  point  at  which  the  function, of J  chain  becomes  essential  in  this 
differentiation process, we have used  a  variety of techniques, both  in vivo and in 
vitro, to assay for its presence within these lines. 
Materials and Methods 
Antisera.  Antibodies to human IgM and ~¢ L  chains were raised in rabbits against purified 
myeloma proteins and affinity-selected as described elsewhere  (15).  One rabbit antiserum to 
human J  chain was obtained from Dr. J. Heremans,  and three different  rabbit antisera  to 
human J  chain (antisera 22, 271 and 321) were kindly provided by Dr. J. Mestecky. One of 
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these, antiserum 22, used for the immunoprecipitations presented in Figs.  1 and 2, has been 
tested by radioimmunoassay and found to be nonreactive to #, a, y, ~, or r  determinants (W. 
H.  Kutteh,  University of Alabama, personal communication).  One  additional rabbit  anti- 
human J  chain antiserum was raised in this laboratory. All antisera were titrated within the 
immunoprecipitation systems described below and checked for specificity at this detection limit 
by cold inhibition with purified proteins (Results). 
Cells and Culture Conditions.  Lymphoblastoid cell lines of different characteristics were chosen 
for study. All were positive for the Epstein-Barr (EB) virus nuclear antigen (EBNA) and for Ia 
antigens, and negative for markers of the T, myeloid, or erythroid series. Most synthesized H 
and/or L  chains  (see Table I). Representative of a  unique group of cell lines were Josh  7a, 
KLM 2, and Josh  7b. These lines, termed round cell lines, are distinguished from previously 
described B  lymphoblastoid lines by the absence of detectable Ig synthesis and  by special 
growth  and  morphologic characteristics. They  are related to  the  B  cell lineage by surface 
marker analysis and possibly represent some type of B precursor cell (15). Josh 4, like Josh  7 
and its subclones, was derived from the bone marrow of a patient with X-linked agammaglob- 
ulinemia and resembles a pre-B cell in its expression of only cytoplasmic # chains (16).  Daudi 
(a Burkitt's lymphoma line), SeD (a chronic lymphocytic leukemia line), and 32a. 1 and RPMI- 
8866P (B lymphoblastoid lines) express various classes of surface and/or secretory Ig; the B line 
Raji was also studied. Other human cell lines used included the T  cell lines Jurkat, CCRF- 
CEM, and KE37; the myeloid lines HL-60 and ML-1; and the monocyte-like line U937. All 
cell lines were maintained in suspension cultures as described previously (15). 
Before pulse labeling with [abS]methionine (700 Ci/mmol)  (New England Nuclear, Boston, 
Mass.), cells were washed twice in phosphate-buffered saline (PBS), resuspended at a concen- 
tration of 4  ×  106 cells/ml in  RPMI-1640  medium  (Microbiogical Associates Bioproducts, 
Walkersville, Md.) that lacked methionine and was supplemented with 5% dialyzed agamma- 
globulinemic horse serum (Grand Island Biological Co., Grand Island N. Y.), and cultured for 
2 h at 37°C. Cells were then pelleted, resuspended in 0.1 ml of the same medium, and pulsed 
with 500/~Ci/ml of [aSS]methionine for 8 min at 37°C.  To follow labeled products in chase 
conditions, cells pulsed in this manner were resuspended to a concentration of 1  .×  106 cells/ml 
in RPMI-1640 that contained methionine, supplemented with 5% agammaglobulinemic horse 
serum, and incubated at 37°C for various time periods. 
Labeled cells were washed twice in ice-cold PBS containing 2 mM  methionine and  then 
lysed in NTET buffer (150 mM NaC1; 20 mM Tris, pH 7.6;  10 mM EDTA; 1% Trasylol) (FBA 
Pharmaceuticals, Inc.,  New  York)  that  contained  1%  Triton X-100  (Rohm  and  Haas Co., 
Philadelphia, Pa.),  10 mM N-ethylmaleimide, and 0.5 #g/ml pepstatin (1 ml/107 cells). After 
20 min on ice with intermittent vortexing, a postnuclear supernate was prepared by centrifu- 
gation at  10,000 rpm for 10 min at 4oC. 
In  Vitro Translation.  Total cellular RNA was prepared from frozen pellets of cells grown in 
mass culture, by an SDS-phenol/chloroform/isoamylalcohol-proteinase  K procedure described 
elsewhere (17).  The LiCl-pr~,itated RNA was washed twice by ethanol precipitation and 
translated in the presence of [  S]methionine in a wheat ~[erm cell-free system (18) optimized 
for salts to give efficient translation of  J chain (3.8 mM Mg  +z, 115 mM KCI). Posttranslationally, 
the samples were adjusted to the conditions of NTET buffer with  1% Triton X-100, and kept 
on ice. 
Immunopredpitation.  Samples that contained [35S]methionine-labeled  polypeptides, generated 
in vivo or in vitro, were immunoprecipitated immediately after adjustment in the Triton X-100 
buffers described above.  The  use of whole rabbit serum  for J  chain  immunoprecipitations 
necessitated a preclearance step with 50/~g of normal rabbit serum for 1 h at room temperature, 
followed by  absorption onto  Sepharose CL-4B  beads coated  with  sheep  anti-rabbit Ig.  In 
preliminary experiments, this preclearance step was found not to precipitate  J chain. Thereafter, 
between  5  and  10  /~l of the  anti-J chain  serum  was  added  to  the  cleared supernates  and 
incubated for 2 h  at room temperature. Immune complexes were absorbed onto sheep anti- 
rabbit Ig Sepharose for  1 h  at 4°C,  rotating on a  wheel. The Sepharose beads were washed 
three  times  in  NTET  buffer  that  contained  1%  Triton  X-100,  once  in  NTET  buffer that 
contained  0.05%  sodium  dodecyl sulfate  (SDS),  twice  in  NTET  buffer  that  contained  no 
detergents, and then resuspended in a polyacrylamide gel electrophoresis loading buffer (2.5% 140  J  CHAIN BIOSYNTHESIS  IN PRECURSOR B CELLS 
SDS, 20% sucrose, 0.008% bromphenol blue, 80 mM Tris-HCl, pH 7, and 50 mM dithiothreitol). 
After 30 min at 37°C, samples were incubated at  100°C for 3 min, and then alkylated in the 
presence of 250 mM iodoacetamide for 30 min at 37°C. 
Gel Electrophoresis.  SDS-polyaerylamide gel electrophoresis  (PAGE) was performed as de- 
scribed  (17). 7.5-15% gradients best resolved intermediates in the biosynthesis of J  chain, but 
10%  gels  served  better  the  resolution  of both J  and  #  chains.  All gels  were run  at  25  mA, 
constant current. 
For analysis of chains by alkaline-urea electrophoresis,  samples were first  run on 7.5-15% 
SDS gels, which were subsequently radioautographed without fixing.  Bands corresponding to 
J  chain in relative mobility were cut out of this first gel and applied to the top of alkaline-urea 
slab gels, prepared as described (19). These gels were then processed for fluorography (20). 
Peptide Maps.  [35S]Methionine-labeled J  chains resolved on unfixed 7.5-15% SDS gels were 
identified by radioautography and peptide mapped by the procedure of Cleveland et al.  (21). 
Details and modifications are outlined in the legend to Fig. 3. 
Results 
The characteristics of the cell lines used in this study are presented in Table I. All 
are positive for EBNA and for Ia. Most can be staged into provisional levels of B cell 
differentiation  by the criteria  of immunoglobulin expression. Josh 4  phenotypically 
resembles a  pre-B cell line in its expression of only cytoplasmic # chains. Daudi, SeD, 
RPMI-8866P,  and  32a. 1  represent  increasingly  differentiated  phenotypes,  ranging 
from the expression of only surface IgM (Daudi)  to the display of an H  chain switch 
in the cases of RPMI-8866P  (y) and 32a. 1 (a). The round cell lines Josh 7 and KLM 
2 are unique cell types that synthesize no functional immunoglobulins. Their pheno- 
typic markers, however, most closely relate them to the B cell lineage. 
J  chain biosynthesis in these lines was probed initially by direct immunoprecipita- 
tion of [SSS]methionine pulse-labeled products. A  fluorograph of one such experiment 
is  shown  in Fig.  1. As expected,  a  radiolabeled  product  comigrating with  human J 
chain  was  observed  in  immunoprecipitates  from  the  polymer-secreting  lines  SeD 
(IgM; lane  1) and 32a. 1 (IgA), from the monomer-secreting line RPMI-8866P (IgG), 
and  from  the  heterogeneous  collection  of B  cell  populations  in  human  tonsil.  In 
addition, however, similar products were found in the Burkitt's lymphoma line Daudi, 
in the pre-B line Josh 4  (lane 2), and in the round cell lines Josh 7a, KLM 2, Josh 7b 
(lanes 4-6, respectively). No products comigrating with J  chain were immunopreeip- 
itated  from the T  cell lines KE37  (lane  7), CCRF-CEM,  and Jurkat;  nor were such 
TABLE  I 
Summary of Primary Cell Lines 
Cell line  Cytoplasmic  Surface Ig*  Secreted Ig:~ 
Ig* 
Josh 7  --  --  -- 
KLM 2  --  --  -- 
Josh 4  p,  --  -- 
Daudi  --  p,,~:  -- 
SeD  #,K  8,p.,•  ~,~: 
RPMI-8866P  y,x  y,K  y,~ 
32.a. 1  a,~  a,)~  a,~ 
* Detected by immunofluorescence. 
:~ Detected by hemagglutination-inhibition and pulse-chase experiments with 
[SSS]methionine. j.  M.  McCUNE,  S.  M.  FU, AND  H.  G.  KUNKEL  141 
FIG.  I.  In vivo biosynthesis of  J chain by B and precursor ceils: SeD (lane 1), Josh 4 (lane 2), Josh 
7a (lane 4), KLM 2 (lane 5), and Josh 7b (lane 6). Cells were pulsed with [~S]methionine  for 30 
rain, immunoprecipitated with rabbit anti-human J  chain antiserum,  and processed for 10% SDS- 
PAGE as described in Materials and Methods. Specificity controls include cold competition of the 
labeled product from Josh 4 with unlabeled J  chain (lane 3) and the absence of labeled immuno- 
precipitates from the non-B cell lines KE37  (lane 7) and U937 (lane 8). The relative mobilities of 
the # H chain and native J chain are indicated on the left. 
Fro.  2.  In vitro biosynthesis of J  chain by B and precursor cells: tonsillar B cells (lane 2), Daudi 
(lane 3), Josh 4 (lane 5), Josh 7a (lane 6), KLM 2 (lane 7), and Josh 7b (lane 8). Products  were 
synthesized in a wheat germ cell-free system from total cellular RNA, immunoprecipitated with 
rabbit  anti-human  J  chain  antiserum,  and  processed  for  7.5-15% SDS-PAGE.  Lane  4:  cold 
competition  of the product from Daudi with native human J  chain;  lane 9:  immunoprecipitate 
from the T  cell line KE37;  lane 1: relative mobility of the primary translation product of the L 
chain from SeD. 
products observed in the cell lines of nonlymphoid origin U937  (lane 8), ML-1, and 
HL-60.  These  results  have  been  repeated  with  five  different  anti-J  chain  antisera 
under a  variety of pulse-chase conditions with no qualitative difference. 
To better define the J  chain-like products synthesized in the pre-B and round cell 
lines, an analysis was undertaken  of their primary translation products, which were 
synthesized in vitro in a  wheat  germ cell-free system. Under these conditions it was 
expected that J  chain would not:  (a) comigrate in unglycosylated form with L chains; 
(b) would not associate--covalently or noncovalently--with H  chains; and  (c) would 
not  be  degraded  or  otherwise  modified;  each  of these  is  a  phenomenon  that  can 
complicate the further  characterization of J  chains synthesized in  vivo  ([19,  22];  cf. 
Fig.  1, lane 1--# from SeD is coprecipitated with J). Fig. 2 is a  fluorograph of  J  chain 
immunoprecipitates from the total translation products of tonsillar B cells and Daudi, 
Josh 4, Josh 7a, KLM  2, Josh 7b, and KE37 cells. All but KE37 yielded a  comigrating 
product,  the  precipitation  of  which,  as  shown  for  Daudi  (lanes  3  and  4),  was 
competitively inhibited  by cold,  native J;  SeD,  RPMI-8866P,  and  32a.1  yielded a 142  J  CHAIN  BIOSYNTHESIS  IN  PRECURSOR  B  CELLS 
similar primary translation product. The relative mobility of the I¢ L chain from SeD 
in such a translation system is included for comparison (lane 1). 
Two additional approaches demonstrated that these primary translation products 
were  indistinguishable  from  the  primary  translation  product  of J  chain  found in 
tonsillar B cells. First, all were found to comigrate, at an acidic isoelectric point, with 
native J  chain by alkaline-urea gel electrophoresis. Second, limited proteolysis with 
Staphylococcus aureus V8 protease generated identical peptide maps from each. Results 
of such an experiment are shown in Fig. 3 for J  chains derived from the tonsillar B 
cells, Josh 4, and KLM 2. 
Discussion 
J  chain has previously been  detected by a  variety of techniques in cells actively 
synthesizing IgM,  IgG,  and  IgA  for secretion  (8,  9,  12,  13), in  myeloma variants 
selected for the loss of H  and/or L  chain synthesis (I0,  11), and within the rough 
endoplasmie reticulum of B cells bearing surface Ig (14). The present study confirms 
these findings and extends them to an analysis of the primary translation product of 
J  chain within each of these and other cell types. In accordance with the findings of 
previous studies, B cells that have differentiated to the point of synthesizing mono- 
merie  immunoglobulin of any class  were  found  to  synthesize J  chain.  New,  and 
apparently at variance with the studies in the mouse system, is the finding of  J  chain 
synthesis in B lineage cells before this stage. 
The above data indicate that J  chain is synthesized in a series of unique human cell 
lines, phenotypically similar to B cell precursors. Present in each is a messenger RNA 
(mRNA) species that, in vitro, encodes the synthesis of a product indistinguishable in 
serologic characteristics, in relative mobility on SDS-PAGE and on alkaline-urea gel 
electrophoresis, and in peptide map from J  chain derived from more differentiated B 
cells.  In vivo, this mRNA is a  functional species, yielding products similar to native 
FIO.  3.  Peptide maps of  J  chain primary translation products from (1) tonsillar B cells, (2) Josh 4, 
and (3) KLM 2. Products were synthesized in vitro, immunoprecipitated with rabbit anti-human J 
chain antiserum, and subjected to electrophoresis on a  7.5-15% SDS-PAGE. Bands corresponding 
to J  chain  were excised from  this  unfixed gel and  again  subjected to  electrophoresis on  a  15% 
polyaerylamide gel in the absence of (-) or presence (+) ofl #g/ml Staphylococcus aureus V8 protease. 
Digestion within the gel proceeded for 30 min at room temperature, at which point the peptides 
were resolved. Arrows on the left indicate five [~S]methionyl peptides shared. J.  M.  McCUNE, S.  M.  FU, AND H. G. KUNKEL  143 
J  chain in pulse-chase experiments. In vivo and in vitro, this product was found only 
in  lines  of proven  or  putative  B  cell  origin  and  not  in  lines  with  T  or  myeloid 
characteristics. The finding of  J  chain in these lines is somewhat surprising in view of 
previous reports. This may be reflective of a difference in the sensitivities of the assays 
used here and those used in the past  (in particular, immunofluorescenee [12]), of a 
species difference in the expression of  J  chain, or of the character of the cell lines used 
in this study. 
The accumulated evidence suggests, but does not prove, that the cell lines studied 
here do in fact represent normal precursors to B cells (15,  16). The round cell lines 
(,Josh  7  and  KLM  2)  are  representative of several  lines,  all  with  similar  growth 
characteristics and morphology. All are positive for EBNA, Ia antigens, Fc receptors, 
C3  receptors, and  negative for markers of the T, myeloid, or erythroid series. The 
finding, in this study, that such cells also synthesize J  chain more firmly places them 
into  the  B  cell  lineage.  That  these  similar  cell  types were  derived  from  different 
patients with several disorders, ranging from monocytic leukemia to X-linked agam- 
maglobulinemia, indicates that they are not reflective of any one particular defect. It 
is likely that  the immortalization of such normal precursor cells in these cases was 
dependent  upon  the  relative deficiency of mature  B  cells  in  these  patients  which 
ordinarily overgrow the cultures. This is evident in the case of Josh 7, derived from 
the bone marrow of a patient with X-linked agammaglobulinemia who had few Ig  + 
cells. The derivation of  Josh 4 from the bone marrow of the same patient adds further 
support  to  this  thesis.  This  line,  in  its  expression  of only  cytoplasmic  #  chain, 
phenotypically fits the description of a normal pre-B cell. 
The ability to detect J  chain in such cells was dependent upon their availability as 
continuously growing  lines,  as well  as  upon  the sensitivity of the  techniques used 
herein. Immunofluorescence does not so clearly demonstrate the presence of J  chain 
as  does either radiolabeling  of cells  in  vivo or  immunoperoxidase staining  in  situ. 
Given the dynamic state of  J  chain in vivo (vis-a-vis chain association, glycosylation, 
and  degradation), even the  results of radiolabeling can  be ambiguous.  A  negative 
result  by  any  of the  above  assays  is,  consequently,  difficult  to  interpret.  Little 
ambiguity exists in the analysis of the total translation products synthesized in vitro 
from these cells: mRNA for J  chain is present, translatable, and (coupled with pulse- 
chase studies)  found to be functional in vivo. It is likely that, if studied by such a 
method, other B cell types once thought deficient will be found, in fact, to synthesize 
J  chain. 
Recent  studies  in  the  mouse  (23)  with  a  transformed  cell  line  with  pre-B  cell 
characteristics indicated that J  chain was not synthesized and not translated in vitro. 
These results are difficult to relate to those of the present studies and the explanation 
of the difference is not apparent. It is conceivable that the EB virus lines utilized in 
this work do not reflect the normal situation. This possibly could apply to the round 
cell lines that showed J  chain translation in vitro without Ig translation. These lines 
could be aberrant  types and not precursors, although they were obtained from the 
bone marrow of widely divergent disorders. However, the pre-B cell line appeared 
typical in all respects and showed J  chain synthesis along with/z chain but not light- 
chain  synthesis.  In  addition,  the  well-known  Raji  line  that  has  been  thought  to 
resemble "pre-B like" cells (24)  also showed synthesis of J  chain. It was also evident 
that the Daudi line, which has membrane Ig but does not secrete, synthesized J  chain. 144  J  CHAIN BIOSYNTHESIS IN PRECURSOR  B CELLS 
The exact stage in the hierarchy of gene activation during B cell ontogeny at which 
J  chain  synthesis  begins remains  to be determined  but  the present  results  indicate 
that it is before secretion. There is no question about the marked increase in J  chain 
synthesis at the later period when Ig synthesis increases and secretion begins (13). 
Irrespective of the final resolution of this question, the detection of  J  chain synthesis 
in the lines without Ig synthesis aided in relating them to cells of B cell lineage. 
Summary 
Human cell lines that resemble precursors in the B cell lineage have been found to 
synthesize J  chain.  In vivo pulse labeling, together with in vitro translation of total 
cellular RNA in a  wheat  germ cell-free system, detected  the synthesis of J  chain in 
immunoglobulin-secreting cell lines, in a cell line with only surface IgM, as well as in 
the pre-B-like cell line Josh 4 and the round cell lines Josh 7 and KLM 2. The primary 
translation products of J  chain from all of these cell lines were found to be indistin- 
guishable  from  one  another  by  serologic  criteria,  by  relative  mobility  on  sodium 
dodecyl sulfate-polyacrylamide gel eleetrophoresis, by charge as judged by alkaline- 
urea  gel  electrophoresis,  and  by peptide  mapping.  These  findings  suggest  that  the 
onset  of J  chain  biosynthesis represents a  relatively early event  in  B  cell ontogeny, 
occurring before the development of immunoglobulin polymer-secreting cells. Its role 
may, consequently,  be fundamental  to the biosynthesis of all  immunoglobulins,  at 
different stages of B cell differentiation. 
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